The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...

NEW YORK (PIX11) – A nose spray has been approved by the U.S. Food and Drug Administration to help treat depression, Johnson & Johnson announced on Tuesday. Spravato is a first-of-its-kind ...

3M cut more than 8,500 jobs, reduced office spaces by 12% and spun off its healthcare business into a listed company. It forecast 2025 adjusted profit of between $7.60 and $7.90 per share ...

3M returned $1.1 billion to shareholders via dividends and share repurchases. Cash from operations of $1.8 billion. Adjusted free cash flow of $1.3 billion.

Still, it’s all about the fun of photography, right? And in that respect the Instax Mini 90 delivers. Why you can trust Digital Camera World Our expert reviewers spend hours testing and comparing ...